DVP // Cell Lines & Virus Cultures OPY-3 of 4/ Khan
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- tbd@fda.gov
- Joshua Holliday joshua.holliday@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Food and Drug Administration is forecasting a new requirement contract for cell lines and virus cultures, designated as DVP OPY-3 of 4/Khan. The opportunity falls under the Analytical Laboratory Instrument Manufacturing NAICS code 334516 and is expected to have its solicitation released on February 1, 2026, with an estimated award date of April 1, 2026. This contract appears to focus on specialized laboratory research materials related to cell and virus cultures.
While specific award values and budget ranges are not detailed in the forecast, the contract involves the Food and Drug Administration and includes two points of contact: Joshua Holliday (joshua.holliday@fda.hhs.gov) from the FDA, and a generic mailbox (tbd@fda.gov). The procurement has no specific set-aside designation, suggesting it is open to a broad range of potential contractors with relevant scientific and laboratory capabilities. Additional specific details about the place of performance, contract duration, or precise scope are not currently available in the forecast.
Forecast text
DVP // Cell Lines & Virus Cultures OPY-3 of 4/ Khan
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast